Efficacy of ipilimumab 3mg/kg following progression on low dose ipilimumab in metastatic melanoma.

被引：0
|
作者：
Lai-Kwon, Julia Elizabeth
Jacques, Sarah
Carlino, Matteo S.
Benannoune, Naima
Robert, Caroline
Allayous, Clara
Baroudjian, Barouyr
Lebbe, Celeste
Zimmer, Lisa
Eroglu, Zeynep
Topcu, Turkan Ozturk
Dimitriou, Florentia
Haydon, Andrew Mark
Lo, Serigne N.
Menzies, Alexander M.
Long, Georgina V.
机构：
[1] Melanoma Inst Australia, Wollstonecraft, Australia
[2] Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
[3] Blacktown Hosp, Blacktown, Australia
[4] Gustave Roussy, Canc Campus, Villejuif, France
[5] Gustave Roussy, Villejuif, France
[6] Paris Saclay Univ, Paris, France
[7] Hop St Louis, AP HP, Dermatol Dept, Paris, France
[8] St Louis Hosp, AP HP, Dept Dermatol, Paris, France
[9] Univ Paris, Hop St Louis, AP HP, Paris, France
[10] Univ Hosp Essen, Dept Dermatol, Essen, Germany
[11] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[12] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA
[13] Univ Zurich Hosp, Zurich, Switzerland
[14] Alfred Hosp, Melbourne, Vic, Australia
[15] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[16] Royal North Shore & Mater Hosp, Sydney, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21533
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II study of the frontline combination of ipilimumab and temozolomide in patients with metastatic melanoma.
    Patel, Sapna Pradyuman
    Hwu, Wen-Jen
    Kim, Kevin B.
    Papadopoulos, Nicholas E.
    Hwu, Patrick
    Radvanyi, Laszlo George
    Mahoney, Sandy
    Deburr, Tawania L.
    Liu, Ping
    Bedikian, Agop Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Ipilimumab (Ipi) retreatment at 10 mg/kg in patients with metastatic melanoma previously treated in phase II trials
    Neyns, Bart
    Weber, Jeffrey S.
    Lebbe, Celeste
    Maio, Michele
    Harmankaya, Kaan
    Hamid, Omid
    O'Day, Steven
    Chin, Kevin M.
    McDowell, Diane Opatt
    Cykowski, Lori
    McHenry, Brent
    Wolchok, Jedd D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Immunological profiling of baseline and resected biopsies from locally/regionally advanced/recurrent melanoma treated with neoadjuvant combination ipilimumab (3mg/kg or 10mg/kg) and high dose IFN-α2B
    Warren, Sarah
    Vallabhaneni, Priyanka
    El-Sawada, Jack
    White, Andrew
    Ren, Xing
    Cesano, Alessandra
    Beechem, Joseph
    Tarhini, Ahmad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [34] US FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab
    Hazarika, Maitreyee
    Chuk, Meredith K.
    Theoret, Marc R.
    Mushti, Sirisha
    He, Kun
    Weis, Shawna L.
    Putman, Alexander H.
    Helms, Whitney S.
    Cao, Xianhua
    Li, Hongshan
    Zhao, Hong
    Zhao, Liang
    Welch, Joel
    Graham, Laurie
    Libeg, Meredith
    Sridhara, Rajeshwari
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3484 - 3488
  • [35] Acute Cholecystitis Following Ipilimumab and Nivolumab Treatment for Metastatic Melanoma
    Somerset, Amy E.
    Field, Bradley M.
    Webber, John D.
    Edelman, David A.
    AMERICAN SURGEON, 2023, 89 (02) : 312 - 313
  • [36] Response to Ipilimumab following Progress on Vemurafenib Therapy in metastatic Melanoma
    Krengel, S.
    Satzger, I
    Kapp, A.
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 929 - 929
  • [37] Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features
    Spain, Lavinia
    Schmid, Thomas
    Gore, Martin
    Larkin, James
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 243 - 244
  • [38] Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.
    Failing, Jarrett
    Finnes, Heidi D.
    Kottschade, Lisa A.
    Allred, Jacob B.
    Markovic, Svetomir
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Clinical characteristics of responders to nivolumab plus ipilimumab (Nivo/Ipi) in metastatic uveal melanoma.
    Shephard, Michael Paul
    Glover, Maura
    Balmes, Gener
    Cain, Suzanne
    Vardeleon, Anna
    Mouton, Rosalind
    Posada, Liberty
    Simien, Rinata
    Hwu, Patrick
    Davies, Michael
    Yee, Cassian
    Wong, Michael
    Tawbi, Hussein
    Woodman, Scott
    Amaria, Rodabe
    Diab, Adi
    Glitza, Isabella
    Hwu, Wen-Jen
    Patel, Sapna
    CANCER RESEARCH, 2020, 80 (19) : 38 - 38
  • [40] Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma
    Kirchberger, Michael C.
    Hauschild, Axel
    Schuler, Gerold
    Heinzerling, Lucie
    EUROPEAN JOURNAL OF CANCER, 2016, 65 : 182 - 184
12345